News

Cartherics granted key patent in China for TAG-72 CAR gene-modified stem cells

Cartherics granted key patent in China for TAG-72 CAR gene-modified stem cells

Melbourne, Australia, 29 January 2026 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, is pleased to announce the granting of a second patent in China for “Genetically modified cells and uses thereof” by the Chinese Patent Office.

This patent extends the Company’s […]

Christine Filippis2026-01-29T11:38:48+11:00January 29th, 2026|

Message from the CEO

Message from the CEO

With the end of the year fast approaching, it is timely to take a step back and reflect on the challenges and achievements for 2025.

We began the year with optimism and momentum, having completed a major financing round late in 2024 (thanks to our incredible group of investors). We were preparing for filing an IND […]

Christine Filippis2025-12-16T15:36:54+11:00December 16th, 2025|

Cartherics to participate in prominent biotech investor conferences during JPM Healthcare Week

Cartherics to participate in prominent biotech investor conferences during JPM Healthcare Week

Dr Ian Nisbet, Chief Executive Officer, is attending both the RESI Investor Conference and BIO Partnering
Dr Vera Evtimov, Director of Operations, is presenting at Biotech Showcase

Melbourne, Australia, 16 December 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead […]

Christine Filippis2025-12-16T14:31:22+11:00December 16th, 2025|

Cartherics Team Offsite: Stronger Together

Cartherics Team Offsite: Stronger Together

The Cartherics team recently gathered at the RACV Club in Healesville for a dynamic and inspiring offsite event focused on collaboration, growth, and celebrating our shared mission.

The theme of the offsite, Stronger Together, set a positive and inclusive tone that resonated throughout the event, encouraging everyone to embrace teamwork, challenges and shared success as we […]

Christine Filippis2025-12-10T10:43:26+11:00December 10th, 2025|

Cartherics to present at the ISSCR 2025 Boston International Symposium

Cartherics to present at the ISSCR 2025 Boston International Symposium

Cartherics’ Deputy Chair, Prof. Alan Trounson AO will be presenting at ISSCR 2025 on Friday 12^th December, 2025 at 3.25pm (US EST)

Melbourne, Australia, 8 December 2025 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and […]

Christine Filippis2025-12-08T16:29:33+11:00December 8th, 2025|

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

Evinco Therapeutics is an Australian start-up on a mission to transform the treatment of Alzheimer’s disease and other neuroinflammatory conditions

Melbourne, Australia, 4 December 2025 – An exciting chapter in medical innovation begins today with the official launch of Evinco Therapeutics Pty Ltd (“Evinco” or “Company”), a Melbourne-based biotechnology company developing advanced immune-based therapies for […]

Christine Filippis2025-12-04T15:17:50+11:00December 4th, 2025|

Cartherics appoints Dr Ian Nisbet as Chief Executive Officer

Cartherics appoints Dr Ian Nisbet as Chief Executive Officer

Dr Ian Nisbet appointed as Chief Executive Officer
Prof Alan Trounson AO will move into the role of Deputy Chair of the Board

Melbourne, Australia, 28 November 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian […]

Christine Filippis2025-11-28T10:15:10+11:00November 28th, 2025|

Cartherics to present at ANZSEV 2025

Cartherics to present at ANZSEV 2025

Cartherics is pleased to announce that it will be presenting at the 8th Australian and New Zealand Society for Extracellular Vesicles (ANZSEV) 2025 Conference in Wellington, New Zealand. ANZSEV 2025 will showcase advances in the field across EVs and biological nanoparticles – their role in cell biology, advances in technologies for their purification and […]

Christine Filippis2025-11-17T11:25:49+11:00November 17th, 2025|

Cartherics achieves clean room certification to support clinical-grade cell therapy manufacturing

Cartherics achieves clean room certification to support clinical-grade cell therapy manufacturing

Cartherics is proud to announce the successful certification of our new clean room facility, marking a significant milestone in our journey toward delivering off-the-shelf cell therapies for cancer and endometriosis.

This milestone builds on the recent unveiling of our cleanroom facility, as announced here, and reflects our continued progress in […]

Christine Filippis2025-10-27T15:16:06+11:00October 27th, 2025|

Cartherics hosts Frocktober afternoon tea for ovarian cancer awareness

Cartherics hosts Frocktober afternoon tea for ovarian cancer awareness

Today, Cartherics proudly hosted a Frocktober Afternoon Tea in support of ovarian cancer awareness and research. Frocktober is a meaningful initiative that encourages us to go the extra style mile – turning heads, starting conversations, and raising vital funds for ovarian cancer research.

We were honoured to welcome Robin Penty, CEO of the Ovarian Cancer Research […]

Christine Filippis2025-10-16T12:08:59+11:00October 15th, 2025|

About us

Sign up to our newsletter